Faecal-immunochemical-test.co.uk aims to raise awareness and provide tailored information to clinicians, laboratory staff, and patients about the purpose and value of testing for faecal occult blood using the FIT immunochemical turbidimetric method, as well as the different support services available.
The Faecal Immunological Test (FIT) is an established bowel cancer test. Utilising a simple picker, the test is a clean and convenient way to check for blood in your poo.
If you have been asked by your Doctor to take a FIT test, you’ll find resources here to assist you with understanding more, and how to take the test itself.
The Faecal Immunochemical Test (FIT) is now an established bowel cancer test. This diagnostic assay identifies the presence of hidden blood in the stool, known as faecal occult blood (FOB), which can be an early sign of colorectal cancer. FIT uses antibodies specific to human haemoglobin so is more accurate and sensitive, provides a quantitative measurement, and gives fewer false positive results than other tests.
Read MoreFor the National Bowel Cancer Screening programmes FIT is bringing many advantages. Easier sampling methods are more acceptable to people invited for screening, which promotes greater uptake. Non-subjective, automated processing of samples advances laboratory efficiencies, improving standardisation and quality control. FIT is more sensitive and can detect cancers more reliably and at an earlier stage than previous methods used.
Read MoreNICE Guidance DG56 recommends “Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care”. NICE concludes that a cut-off of 10 μg of Hb/ g faeces in a FIT has a high negative predictive value for colorectal cancer and other serious bowel diseases, therefore, FIT should be used to triage for referral to secondary care, people whose symptoms suggest colorectal cancer, but in whom a definitive diagnosis of cancer is unlikely.
Read More
Author: Kayleigh Roberts, Product Manager, Alpha Laboratories Ltd. At the onset of the COVID-19 pandemic, the global healthcare landscape had to undergo a swift transformation. Traditional face-to-face healthcare delivery was significantly disrupted, and accommodations had to be made to ensure that patients could be triaged and monitored in ways that protected public health and also…
The Bowel Screening Laboratory in Wales have been running the Alpha Laboratories Faecal Immunochemical Testing (FIT) kits on the HM-JACKarc analyser for over five years. The lab runs around 350,000 FIT tests per annum and have recently changed their control reagents from lyophilised controls to the new innovative liquid controls. Andrew Jones, the Laboratory Section…
Author: Kayleigh Roberts, Senior Product Manager FIT, Alpha Laboratories What is Bowel Cancer Screening? From breast to bowel, in the UK we are lucky to have free and comprehensive screening programmes that can help to detect common cancers and conditions before they show obvious symptoms or become more serious. Screening programmes typically target those at…
